ClinicalTrials.Veeva

Menu

Transesophageal Echocardiography: Dysphagia Risk in Acute Stroke (T.E.D.R.A.S. Trial) (TEDRAS)

U

University of Giessen

Status

Completed

Conditions

Dysphagia
Swallowing Disorder
Acute Stroke

Treatments

Diagnostic Test: Transesophageal Echocardiography (TEE)
Diagnostic Test: Flexible Endoscopic Evaluation of Swallowing

Study type

Interventional

Funder types

Other

Identifiers

NCT04302883
TEDRAS-1

Details and patient eligibility

About

The prevalence of dysphagia in acute stroke patients undergoing transesophageal echocardiography (TEE) is unknown. The aim of this study was to assess for the first time whether TEE has a negative influence on swallowing in acute stroke patients.

Full description

Dysphagia is common in patients with acute stroke and deteriorates the overall outcome (1). Transesophageal echocardiography (TEE) is a routine examination in the diagnostic workup of stroke etiology. In cardiac surgery it is known as cause of postoperative dysphagia (2).

Using flexible endoscopic evaluation of swallowing (FEES) T.E.D.R.A.S., as a prospective, blinded, randomized and controlled study, includes patients in two groups in order to test the influence of TEE on swallowing in acute stroke: an intervention group and a control group. FEES is performed for analysis of swallowing in the intervention group (1) one day before TEE, (2) 2-4 hours after TEE, (3) 24 hours after TEE. In the control group FEES is performed on three consecutive days with TEE taking place any time after the last FEES. Validated scores assess dysphagia severity in both groups.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute stroke (max. 7 days post-onset) as displayed by a cranial computed tomography (CT) or magnetic resonance imaging (MRI)
  • written informed consent either by patients themselves or by a legal representative
  • indication for TEE

Exclusion criteria

  • brain hemorrhage
  • either pre-existing neurogenic dysphagia or
  • head-and-neck cancer induced dysphagia
  • dementia
  • aphasia with an impairment in language comprehension

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

34 participants in 2 patient groups

Intervention group
Experimental group
Description:
TEE FEES
Treatment:
Diagnostic Test: Flexible Endoscopic Evaluation of Swallowing
Diagnostic Test: Transesophageal Echocardiography (TEE)
Control group
Active Comparator group
Description:
FEES
Treatment:
Diagnostic Test: Flexible Endoscopic Evaluation of Swallowing
Diagnostic Test: Transesophageal Echocardiography (TEE)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems